Biocept, Providence Saint Joseph’s Health Center Collaborate on CSF Liquid Biopsy Testing

Biocept announced that it has partnered with Providence St. Joseph Health, Southern California, and its affiliates Saint John’s Health Center and the John Wayne Cancer Institute, to evaluate usage of cerebral spinal fluid (CSF) in liquid biopsy testing for metastatic cancer.

Target Selector liquid biopsy platform to test CSF samples from patients diagnosed with certain types of cancer, including breast, lung, and melanoma, as well as other malignancies to determine if leptomeningeal metastases (LM) has occurred. Researchers will then compare the results to standard methods of testing to confirm the diagnosis.

Source: https://www.genomeweb.com/molecular-diagnostics/biocept-providence-saint-josephs-health-center-collaborate-csf-liquid-biopsy